Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 17/11/20141 min de lecture
Smith Miller and Patch, Inc. et al.; Withdrawal of Approval of 14 New Drug Applications
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is withdrawing approval of 14 new drug applications (NDAs) from multiple holders of these applications. The basis for the withdrawals is that the holders of the applications have repeatedly failed to file required annual reports for the applications.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →